Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,812 | 229 | 98.3% |
| Education | $65.99 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $645.12 | 49 | $0 (2024) |
| Alkermes, Inc. | $273.76 | 15 | $0 (2024) |
| Novo Nordisk Inc | $182.11 | 12 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $179.38 | 10 | $0 (2023) |
| Astellas Pharma US Inc | $167.38 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $149.83 | 8 | $0 (2024) |
| Lilly USA, LLC | $142.28 | 9 | $0 (2024) |
| Corcept Therapeutics | $132.48 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $118.40 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $105.58 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $901.92 | 54 | ABBVIE INC. ($183.23) |
| 2023 | $1,133 | 62 | ABBVIE INC. ($163.73) |
| 2022 | $1,057 | 61 | Alkermes, Inc. ($94.17) |
| 2021 | $786.56 | 53 | AbbVie Inc. ($207.05) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Obesity | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Biological | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Endocrinology | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PAIN | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: CNS | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: PSYCHIATRY | ||||||
| 07/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 183 | 206 | $39,398 | $13,238 |
| 2022 | 4 | 145 | 165 | $32,984 | $11,062 |
| 2021 | 3 | 95 | 99 | $17,833 | $6,707 |
| 2020 | 3 | 76 | 88 | $16,001 | $4,262 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 76 | $10,716 | $3,295 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 49 | $10,145 | $2,874 | 28.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 18 | $5,706 | $2,357 | 41.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $4,704 | $2,187 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,400 | $1,374 | 21.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,342 | $828.35 | 61.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $322.96 | 83.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 72 | $10,152 | $3,559 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 49 | $10,192 | $3,429 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $9,280 | $2,474 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $3,360 | $1,599 | 47.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 38 | $7,904 | $2,813 | 35.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 45 | $6,345 | $2,144 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $3,584 | $1,750 | 48.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 40 | $8,320 | $1,924 | 23.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 37 | $5,217 | $1,387 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,464 | $951.28 | 38.6% |
About Rachel Baker, APRN, FNP-C
Rachel Baker, APRN, FNP-C is a Family healthcare provider based in Sylvania, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2019. The National Provider Identifier (NPI) number assigned to this provider is 1629533930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Baker, APRN, FNP-C has received a total of $3,878 in payments from pharmaceutical and medical device companies, with $901.92 received in 2024. These payments were reported across 230 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($3,812).
As a Medicare-enrolled provider, Baker has provided services to 499 Medicare beneficiaries, totaling 558 services with total Medicare billing of $35,269. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Sylvania, OH
- Active Since 01/31/2019
- Last Updated 01/31/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1629533930
Products in Payments
- VRAYLAR (Drug) $393.95
- ARISTADA (Drug) $203.16
- NURTEC ODT (Drug) $176.63
- TRINTELLIX (Drug) $149.83
- REXULTI (Drug) $140.36
- Korlym (Drug) $132.48
- AUSTEDO (Drug) $127.73
- UBRELVY (Drug) $124.59
- QUVIVIQ (Drug) $105.03
- Kerendia (Drug) $87.80
- BELSOMRA (Drug) $86.39
- GEMTESA (Drug) $83.53
- Cologuard Collection Kit (Device) $79.80
- QULIPTA (Drug) $77.35
- CAPLYTA (Drug) $77.17
- Vascepa (Drug) $71.18
- Wegovy (Drug) $70.92
- APLENZIN (Drug) $69.77
- FREESTYLE LIBRE 3 (Device) $65.25
- Rybelsus (Drug) $64.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sylvania
Kelsey Cutcher
Family — Payments: $7,098
Stacie Kregel, Cnp, CNP
Family — Payments: $5,813
Mindy Howard, Fnp, FNP
Family — Payments: $4,394
Allison Rublaitus
Family — Payments: $3,425
Amy Butler, Aprn, Cnp, APRN, CNP
Family — Payments: $2,086
Kendra Watts, Cnp, CNP
Family — Payments: $2,055